Thymosin Alpha-1 Dosage: What Sick People Received
This protein is used as medicine abroad. You'll see what studies gave patients and why those amounts don't set your dose.
What the study amounts mean for your care
Used abroad as medicine, Thymosin Alpha-1 is a body-made protein. This page tells you what watched studies gave sick people. No line here sets your amount. One illness and one study stood behind each amount.
An under-skin shot was the usual route in these studies. Amounts were counted in milligrams, written as mg. One-time amounts ran from 0.8 to 6.4 mg. Liver studies often used 1.6 mg twice a week under a doctor's watch.
The drug has a 2-hour half-life, meaning its blood level falls by half in about that time. There is no official US dose because the drug isn't approved here. Your age, health, and medicine list still affect that choice. You need a doctor who knows all three.
What the Thymosin alpha 1 dosage ranges show
The range was wide. One-time shots ran from 0.8 to 6.4 mg. Several shots given during five to seven days added up to 1.6 to 16 mg [4]. For long-term hepatitis B and C, the best-known plan used 1.6 mg twice a week [4].
Sepsis studies gave 1.6 mg every 12 hours for five to seven days [2][3]. COVID-19 records listed 1.6 mg each day [6]. Cancer studies used 1.6 mg twice a week beside other care [7]. The illness changed both the amount and timing.
These aren't numbers for you to copy. Doctors watched the patients and knew their health problems. The largest sepsis study used one of these plans and still found no benefit. A study amount can't promise that your health will improve.
What changed when the illness changed
The illness set each Thymosin Alpha-1 study plan. Studies lasting years in hepatitis B or C used 1.6 mg twice a week [4]. That doesn't mean the same plan fits another illness. It also doesn't mean the plan fits you.
The earlier severe sepsis study used 1.6 mg every 12 hours for five days, then once daily for two days [2]. The later phase-3 sepsis test used 1.6 mg every 12 hours for seven days [3]. COVID-19 charts listed 1.6 mg each day [6]. Cancer studies listed 1.6 mg twice a week with other care [7].
The amount stayed at 1.6 mg in these examples, but the timing changed. Each plan belonged to one closely watched study. The every-12-hour plan in the large phase-3 sepsis test left the death rate unchanged [3]. A repeated number doesn't prove a plan will help you.
What your body does after a Thymosin alpha 1 injection
Most human studies used a shot under the skin [4]. Blood held the highest amount after about one to two hours. About two hours later, the amount was half as high. It neared the starting level within about 24 hours.
Long-term plans often used two shots a week. Short, grave illnesses sometimes used a shot every 12 hours. Those timings came from watched studies, not a safe plan for your body. They also don't show that the drug worked.
Blood and body tissue break down the protein [4]. It comes as freeze-dried powder, and a small group of atoms on one end is needed for it to work [1]. People say mixing a vial and keeping it free of germs can be hard. A research vial is sold for lab work, so you can't be sure of its contents or strength [4].
Why a study can't choose your amount
Thymosin Alpha-1, also called thymalfasin, is approved abroad but not in the United States. The amounts above came from watched studies of people with set illnesses. They don't establish a safe amount for your body. Your own health changes that choice.
This page only reports what each study used. It won't turn those numbers into your plan. For personal reports and known risks, read Thymosin Alpha-1 effects. Your doctor can weigh the risk after reviewing your health record and every medicine you take.